These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16676271)

  • 41. Synthetic analogs of natural glycosides in drug discovery and development.
    Grynkiewicz G; Szeja W; Boryski J
    Acta Pol Pharm; 2008; 65(6):655-76. PubMed ID: 19172847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidimensional separation and hyphenated techniques in pharmaceutical research: practical considerations.
    Cheng X
    Drug Discov Today; 2004 Apr; 9(7):305-6. PubMed ID: 15037228
    [No Abstract]   [Full Text] [Related]  

  • 44. Chemistry strategies in early drug discovery: an overview of recent trends.
    Colombo M; Peretto I
    Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the reactions used for the preparation of drug candidate molecules.
    Carey JS; Laffan D; Thomson C; Williams MT
    Org Biomol Chem; 2006 Jun; 4(12):2337-47. PubMed ID: 16763676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic approaches to the 2010 new drugs.
    Liu KK; Sakya SM; O'Donnell CJ; Flick AC; Ding HX
    Bioorg Med Chem; 2012 Feb; 20(3):1155-74. PubMed ID: 22261026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging applications of network and pathway analysis in drug discovery and development.
    Ganter B; Giroux CN
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):86-94. PubMed ID: 18175271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multicomponent reactions in solid-phase synthesis.
    Banfi L; Guanti G; Riva R; Basso A
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):704-14. PubMed ID: 17987522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug discovery beyond the 'rule-of-five'.
    Zhang MQ; Wilkinson B
    Curr Opin Biotechnol; 2007 Dec; 18(6):478-88. PubMed ID: 18035532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
    Beaumont K; Smith DA
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
    Baillie TA
    Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations.
    Gabrielsson J; Dolgos H; Gillberg PG; Bredberg U; Benthem B; Duker G
    Drug Discov Today; 2009 Apr; 14(7-8):358-72. PubMed ID: 19162219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Automated approach to couple solubility with final pH and crystallinity for pharmaceutical discovery compounds.
    Seadeek C; Ando H; Bhattachar SN; Heimbach T; Sonnenberg JL; Blackburn AC
    J Pharm Biomed Anal; 2007 Apr; 43(5):1660-6. PubMed ID: 17270379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of lean manufacturing concepts to drug discovery: rapid analogue library synthesis.
    Weller HN; Nirschl DS; Petrillo EW; Poss MA; Andres CJ; Cavallaro CL; Echols MM; Grant-Young KA; Houston JG; Miller AV; Swann RT
    J Comb Chem; 2006; 8(5):664-9. PubMed ID: 16961404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds.
    Ertl P; Jelfs S; Mühlbacher J; Schuffenhauer A; Selzer P
    J Med Chem; 2006 Jul; 49(15):4568-73. PubMed ID: 16854061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W
    J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.